Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.27 USD | -2.43% | -3.63% | -9.11% |
05-30 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
05-20 | BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda | MT |
Sales 2024 * | 14.91M 20.29M | Sales 2025 * | 82.05M 112M | Capitalization | 1.16B 1.58B |
---|---|---|---|---|---|
Net income 2024 * | -247M -336M | Net income 2025 * | -202M -275M | EV / Sales 2024 * | 64.6 x |
Net cash position 2024 * | 196M 267M | Net cash position 2025 * | 212M 289M | EV / Sales 2025 * | 11.5 x |
P/E ratio 2024 * |
-4.72
x | P/E ratio 2025 * |
-6.21
x | Employees | 174 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.28% |
Latest transcript on Day One Biopharmaceuticals, Inc.
1 day | -2.43% | ||
1 week | -3.63% | ||
1 month | -24.47% | ||
3 months | -24.00% | ||
6 months | +8.24% | ||
Current year | -9.11% |
Managers | Title | Age | Since |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 18-10-31 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 20-08-31 |
Charles York
DFI | Director of Finance/CFO | 47 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 21-08-16 |
Natalie Holles
BRD | Director/Board Member | 51 | 21-01-31 |
John Josey
BRD | Director/Board Member | 63 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 13.27 | -2.43% | 1,108,019 |
24-05-30 | 13.6 | -1.16% | 1,052,160 |
24-05-29 | 13.76 | +1.10% | 522,069 |
24-05-28 | 13.61 | -1.16% | 1,598,046 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.11% | 1.16B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- DAWN Stock